Literature DB >> 14654261

Japanese version of the MD Anderson Symptom Inventory: a validation study.

Toru Okuyama1, Xin Shelley Wang, Tatsuo Akechi, Tito R Mendoza, Takashi Hosaka, Charles S Cleeland, Yosuke Uchitomi.   

Abstract

Cancer patients frequently suffer from a myriad of symptoms. The development and application of comprehensive assessment tools is essential to the effective management of these symptoms. The M.D. Anderson Symptom Inventory (MDASI), developed in English, is a brief, self-rating multiple symptom assessment scale that consists of 13 symptom items and 6 interference items. We examined the validity and reliability of the Japanese version of this scale (MDASI-J) by evaluating 252 randomly selected cancer patients. They were asked to self-administer the MDASI-J and the European Organization for Research and Treatment of Cancer QLQ-C 30. Construct, criterion, convergent and discriminant validity, and reliability of the MDASI-J were evaluated and compared with corresponding data obtained in the previous study conducted in the United States. The results indicated that the MDASI-J is a valid and practical measure for assessing multiple symptoms in Japanese cancer patients. Both factor analysis and cluster analysis showed the consistency of the statistical structure of the English and Japanese versions, indicating the cross-cultural validity of the scale.

Entities:  

Mesh:

Year:  2003        PMID: 14654261     DOI: 10.1016/j.jpainsymman.2003.05.003

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  44 in total

1.  Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.

Authors:  Tito R Mendoza; Xin Shelley Wang; Charles Lu; Guadalupe R Palos; Zhongxing Liao; Gary M Mobley; Shitij Kapoor; Charles S Cleeland
Journal:  Oncologist       Date:  2011-02-01

2.  The association between symptom burdens and utility in Chinese cancer patients.

Authors:  Ya-Chen Tina Shih; Xin Shelley Wang; Scott B Cantor; Charles S Cleeland
Journal:  Qual Life Res       Date:  2006-06-22       Impact factor: 4.147

3.  Cancer symptom clusters--a dynamic construct.

Authors:  Jordanka Kirkova; Declan Walsh
Journal:  Support Care Cancer       Date:  2007-05-04       Impact factor: 3.603

4.  Changing the perspective: current trends in the assessment of functional outcome in patients with head and neck cancer.

Authors:  Uta Tschiesner
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

5.  Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy.

Authors:  Seiko Bun; Kan Yonemori; Toru Akagi; Emi Noguchi; Tatsunori Shimoi; Akihiko Shimomura; Mayu Yunokawa; Chikako Shimizu; Yasuhiro Fujiwara; Yoshinori Makino; Yoshikazu Hayashi; Kenji Tamura
Journal:  Invest New Drugs       Date:  2017-07-21       Impact factor: 3.850

6.  Impact of cultural and linguistic factors on symptom reporting by patients with cancer.

Authors:  Xin Shelley Wang; Charles S Cleeland; Tito R Mendoza; Young Ho Yun; Ying Wang; Toru Okuyama; Valen E Johnson
Journal:  J Natl Cancer Inst       Date:  2010-03-26       Impact factor: 13.506

7.  Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module.

Authors:  G Brandon Gunn; Michael I Koukourakis; Tito R Mendoza; Charles S Cleeland; David I Rosenthal
Journal:  Forum Clin Oncol       Date:  2012-03

8.  Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module.

Authors:  Shota Tanaka; Iori Sato; Masamichi Takahashi; Terri S Armstrong; Charles S Cleeland; Tito R Mendoza; Akitake Mukasa; Shunsaku Takayanagi; Yoshitaka Narita; Kiyoko Kamibeppu; Nobuhito Saito
Journal:  Jpn J Clin Oncol       Date:  2020-07-09       Impact factor: 3.019

9.  Symptom clusters in patients with advanced cancers.

Authors:  Winson Y Cheung; Lisa W Le; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2009-01-30       Impact factor: 3.603

10.  A longitudinal study of the role of patient-reported outcomes on survival prediction of palliative cancer inpatients in Taiwan.

Authors:  Jing-An Chang; Chia-Chin Lin
Journal:  Support Care Cancer       Date:  2009-02-12       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.